Global Viral Inactivation Market Research Report 2024(Status and Outlook)
Report Overview:
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
The Global Viral Inactivation Market Size was estimated at USD 556.56 million in 2023 and is projected to reach USD 991.38 million by 2029, exhibiting a CAGR of 10.10% during the forecast period.
This report provides a deep insight into the global Viral Inactivation market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Viral Inactivation Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Viral Inactivation market in any manner.
Global Viral Inactivation Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Danaher
Merck
Parker Hannifin
Sartorius
SGS
Charles River Laboratories International
Clean Cells
Rad Source Technologies
Texcell
Viral Inactivated Plasma Systems
Wuxi Pharmatech (Cayman)
Market Segmentation (by Type)
Kits and Reagents
Services
Viral Inactivation Systems and Accessories
Market Segmentation (by Application)
Blood and Blood Products
Cellular and Gene Therapy Products
Stem Cell Products
Tissue and Tissue Products
Vaccines and Therapeutics
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Inactivation Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
The Global Viral Inactivation Market Size was estimated at USD 556.56 million in 2023 and is projected to reach USD 991.38 million by 2029, exhibiting a CAGR of 10.10% during the forecast period.
This report provides a deep insight into the global Viral Inactivation market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Viral Inactivation Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Viral Inactivation market in any manner.
Global Viral Inactivation Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Danaher
Merck
Parker Hannifin
Sartorius
SGS
Charles River Laboratories International
Clean Cells
Rad Source Technologies
Texcell
Viral Inactivated Plasma Systems
Wuxi Pharmatech (Cayman)
Market Segmentation (by Type)
Kits and Reagents
Services
Viral Inactivation Systems and Accessories
Market Segmentation (by Application)
Blood and Blood Products
Cellular and Gene Therapy Products
Stem Cell Products
Tissue and Tissue Products
Vaccines and Therapeutics
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Viral Inactivation Market
- Overview of the regional outlook of the Viral Inactivation Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Inactivation Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Viral Inactivation
1.2 Key Market Segments
1.2.1 Viral Inactivation Segment by Type
1.2.2 Viral Inactivation Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VIRAL INACTIVATION MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VIRAL INACTIVATION MARKET COMPETITIVE LANDSCAPE
3.1 Global Viral Inactivation Revenue Market Share by Company (2019-2024)
3.2 Viral Inactivation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Viral Inactivation Market Size Sites, Area Served, Product Type
3.4 Viral Inactivation Market Competitive Situation and Trends
3.4.1 Viral Inactivation Market Concentration Rate
3.4.2 Global 5 and 10 Largest Viral Inactivation Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 VIRAL INACTIVATION VALUE CHAIN ANALYSIS
4.1 Viral Inactivation Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VIRAL INACTIVATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 VIRAL INACTIVATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viral Inactivation Market Size Market Share by Type (2019-2024)
6.3 Global Viral Inactivation Market Size Growth Rate by Type (2019-2024)
7 VIRAL INACTIVATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viral Inactivation Market Size (M USD) by Application (2019-2024)
7.3 Global Viral Inactivation Market Size Growth Rate by Application (2019-2024)
8 VIRAL INACTIVATION MARKET SEGMENTATION BY REGION
8.1 Global Viral Inactivation Market Size by Region
8.1.1 Global Viral Inactivation Market Size by Region
8.1.2 Global Viral Inactivation Market Size Market Share by Region
8.2 North America
8.2.1 North America Viral Inactivation Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Viral Inactivation Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Viral Inactivation Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Viral Inactivation Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Viral Inactivation Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Danaher
9.1.1 Danaher Viral Inactivation Basic Information
9.1.2 Danaher Viral Inactivation Product Overview
9.1.3 Danaher Viral Inactivation Product Market Performance
9.1.4 Danaher Viral Inactivation SWOT Analysis
9.1.5 Danaher Business Overview
9.1.6 Danaher Recent Developments
9.2 Merck
9.2.1 Merck Viral Inactivation Basic Information
9.2.2 Merck Viral Inactivation Product Overview
9.2.3 Merck Viral Inactivation Product Market Performance
9.2.4 Danaher Viral Inactivation SWOT Analysis
9.2.5 Merck Business Overview
9.2.6 Merck Recent Developments
9.3 Parker Hannifin
9.3.1 Parker Hannifin Viral Inactivation Basic Information
9.3.2 Parker Hannifin Viral Inactivation Product Overview
9.3.3 Parker Hannifin Viral Inactivation Product Market Performance
9.3.4 Danaher Viral Inactivation SWOT Analysis
9.3.5 Parker Hannifin Business Overview
9.3.6 Parker Hannifin Recent Developments
9.4 Sartorius
9.4.1 Sartorius Viral Inactivation Basic Information
9.4.2 Sartorius Viral Inactivation Product Overview
9.4.3 Sartorius Viral Inactivation Product Market Performance
9.4.4 Sartorius Business Overview
9.4.5 Sartorius Recent Developments
9.5 SGS
9.5.1 SGS Viral Inactivation Basic Information
9.5.2 SGS Viral Inactivation Product Overview
9.5.3 SGS Viral Inactivation Product Market Performance
9.5.4 SGS Business Overview
9.5.5 SGS Recent Developments
9.6 Charles River Laboratories International
9.6.1 Charles River Laboratories International Viral Inactivation Basic Information
9.6.2 Charles River Laboratories International Viral Inactivation Product Overview
9.6.3 Charles River Laboratories International Viral Inactivation Product Market Performance
9.6.4 Charles River Laboratories International Business Overview
9.6.5 Charles River Laboratories International Recent Developments
9.7 Clean Cells
9.7.1 Clean Cells Viral Inactivation Basic Information
9.7.2 Clean Cells Viral Inactivation Product Overview
9.7.3 Clean Cells Viral Inactivation Product Market Performance
9.7.4 Clean Cells Business Overview
9.7.5 Clean Cells Recent Developments
9.8 Rad Source Technologies
9.8.1 Rad Source Technologies Viral Inactivation Basic Information
9.8.2 Rad Source Technologies Viral Inactivation Product Overview
9.8.3 Rad Source Technologies Viral Inactivation Product Market Performance
9.8.4 Rad Source Technologies Business Overview
9.8.5 Rad Source Technologies Recent Developments
9.9 Texcell
9.9.1 Texcell Viral Inactivation Basic Information
9.9.2 Texcell Viral Inactivation Product Overview
9.9.3 Texcell Viral Inactivation Product Market Performance
9.9.4 Texcell Business Overview
9.9.5 Texcell Recent Developments
9.10 Viral Inactivated Plasma Systems
9.10.1 Viral Inactivated Plasma Systems Viral Inactivation Basic Information
9.10.2 Viral Inactivated Plasma Systems Viral Inactivation Product Overview
9.10.3 Viral Inactivated Plasma Systems Viral Inactivation Product Market Performance
9.10.4 Viral Inactivated Plasma Systems Business Overview
9.10.5 Viral Inactivated Plasma Systems Recent Developments
9.11 Wuxi Pharmatech (Cayman)
9.11.1 Wuxi Pharmatech (Cayman) Viral Inactivation Basic Information
9.11.2 Wuxi Pharmatech (Cayman) Viral Inactivation Product Overview
9.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Product Market Performance
9.11.4 Wuxi Pharmatech (Cayman) Business Overview
9.11.5 Wuxi Pharmatech (Cayman) Recent Developments
10 VIRAL INACTIVATION REGIONAL MARKET FORECAST
10.1 Global Viral Inactivation Market Size Forecast
10.2 Global Viral Inactivation Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Viral Inactivation Market Size Forecast by Country
10.2.3 Asia Pacific Viral Inactivation Market Size Forecast by Region
10.2.4 South America Viral Inactivation Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Viral Inactivation by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Viral Inactivation Market Forecast by Type (2025-2030)
11.2 Global Viral Inactivation Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Viral Inactivation
1.2 Key Market Segments
1.2.1 Viral Inactivation Segment by Type
1.2.2 Viral Inactivation Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VIRAL INACTIVATION MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VIRAL INACTIVATION MARKET COMPETITIVE LANDSCAPE
3.1 Global Viral Inactivation Revenue Market Share by Company (2019-2024)
3.2 Viral Inactivation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Viral Inactivation Market Size Sites, Area Served, Product Type
3.4 Viral Inactivation Market Competitive Situation and Trends
3.4.1 Viral Inactivation Market Concentration Rate
3.4.2 Global 5 and 10 Largest Viral Inactivation Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 VIRAL INACTIVATION VALUE CHAIN ANALYSIS
4.1 Viral Inactivation Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VIRAL INACTIVATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 VIRAL INACTIVATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viral Inactivation Market Size Market Share by Type (2019-2024)
6.3 Global Viral Inactivation Market Size Growth Rate by Type (2019-2024)
7 VIRAL INACTIVATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viral Inactivation Market Size (M USD) by Application (2019-2024)
7.3 Global Viral Inactivation Market Size Growth Rate by Application (2019-2024)
8 VIRAL INACTIVATION MARKET SEGMENTATION BY REGION
8.1 Global Viral Inactivation Market Size by Region
8.1.1 Global Viral Inactivation Market Size by Region
8.1.2 Global Viral Inactivation Market Size Market Share by Region
8.2 North America
8.2.1 North America Viral Inactivation Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Viral Inactivation Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Viral Inactivation Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Viral Inactivation Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Viral Inactivation Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Danaher
9.1.1 Danaher Viral Inactivation Basic Information
9.1.2 Danaher Viral Inactivation Product Overview
9.1.3 Danaher Viral Inactivation Product Market Performance
9.1.4 Danaher Viral Inactivation SWOT Analysis
9.1.5 Danaher Business Overview
9.1.6 Danaher Recent Developments
9.2 Merck
9.2.1 Merck Viral Inactivation Basic Information
9.2.2 Merck Viral Inactivation Product Overview
9.2.3 Merck Viral Inactivation Product Market Performance
9.2.4 Danaher Viral Inactivation SWOT Analysis
9.2.5 Merck Business Overview
9.2.6 Merck Recent Developments
9.3 Parker Hannifin
9.3.1 Parker Hannifin Viral Inactivation Basic Information
9.3.2 Parker Hannifin Viral Inactivation Product Overview
9.3.3 Parker Hannifin Viral Inactivation Product Market Performance
9.3.4 Danaher Viral Inactivation SWOT Analysis
9.3.5 Parker Hannifin Business Overview
9.3.6 Parker Hannifin Recent Developments
9.4 Sartorius
9.4.1 Sartorius Viral Inactivation Basic Information
9.4.2 Sartorius Viral Inactivation Product Overview
9.4.3 Sartorius Viral Inactivation Product Market Performance
9.4.4 Sartorius Business Overview
9.4.5 Sartorius Recent Developments
9.5 SGS
9.5.1 SGS Viral Inactivation Basic Information
9.5.2 SGS Viral Inactivation Product Overview
9.5.3 SGS Viral Inactivation Product Market Performance
9.5.4 SGS Business Overview
9.5.5 SGS Recent Developments
9.6 Charles River Laboratories International
9.6.1 Charles River Laboratories International Viral Inactivation Basic Information
9.6.2 Charles River Laboratories International Viral Inactivation Product Overview
9.6.3 Charles River Laboratories International Viral Inactivation Product Market Performance
9.6.4 Charles River Laboratories International Business Overview
9.6.5 Charles River Laboratories International Recent Developments
9.7 Clean Cells
9.7.1 Clean Cells Viral Inactivation Basic Information
9.7.2 Clean Cells Viral Inactivation Product Overview
9.7.3 Clean Cells Viral Inactivation Product Market Performance
9.7.4 Clean Cells Business Overview
9.7.5 Clean Cells Recent Developments
9.8 Rad Source Technologies
9.8.1 Rad Source Technologies Viral Inactivation Basic Information
9.8.2 Rad Source Technologies Viral Inactivation Product Overview
9.8.3 Rad Source Technologies Viral Inactivation Product Market Performance
9.8.4 Rad Source Technologies Business Overview
9.8.5 Rad Source Technologies Recent Developments
9.9 Texcell
9.9.1 Texcell Viral Inactivation Basic Information
9.9.2 Texcell Viral Inactivation Product Overview
9.9.3 Texcell Viral Inactivation Product Market Performance
9.9.4 Texcell Business Overview
9.9.5 Texcell Recent Developments
9.10 Viral Inactivated Plasma Systems
9.10.1 Viral Inactivated Plasma Systems Viral Inactivation Basic Information
9.10.2 Viral Inactivated Plasma Systems Viral Inactivation Product Overview
9.10.3 Viral Inactivated Plasma Systems Viral Inactivation Product Market Performance
9.10.4 Viral Inactivated Plasma Systems Business Overview
9.10.5 Viral Inactivated Plasma Systems Recent Developments
9.11 Wuxi Pharmatech (Cayman)
9.11.1 Wuxi Pharmatech (Cayman) Viral Inactivation Basic Information
9.11.2 Wuxi Pharmatech (Cayman) Viral Inactivation Product Overview
9.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Product Market Performance
9.11.4 Wuxi Pharmatech (Cayman) Business Overview
9.11.5 Wuxi Pharmatech (Cayman) Recent Developments
10 VIRAL INACTIVATION REGIONAL MARKET FORECAST
10.1 Global Viral Inactivation Market Size Forecast
10.2 Global Viral Inactivation Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Viral Inactivation Market Size Forecast by Country
10.2.3 Asia Pacific Viral Inactivation Market Size Forecast by Region
10.2.4 South America Viral Inactivation Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Viral Inactivation by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Viral Inactivation Market Forecast by Type (2025-2030)
11.2 Global Viral Inactivation Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Viral Inactivation Market Size Comparison by Region (M USD)
Table 5. Global Viral Inactivation Revenue (M USD) by Company (2019-2024)
Table 6. Global Viral Inactivation Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Inactivation as of 2022)
Table 8. Company Viral Inactivation Market Size Sites and Area Served
Table 9. Company Viral Inactivation Product Type
Table 10. Global Viral Inactivation Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Viral Inactivation
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Viral Inactivation Market Challenges
Table 18. Global Viral Inactivation Market Size by Type (M USD)
Table 19. Global Viral Inactivation Market Size (M USD) by Type (2019-2024)
Table 20. Global Viral Inactivation Market Size Share by Type (2019-2024)
Table 21. Global Viral Inactivation Market Size Growth Rate by Type (2019-2024)
Table 22. Global Viral Inactivation Market Size by Application
Table 23. Global Viral Inactivation Market Size by Application (2019-2024) & (M USD)
Table 24. Global Viral Inactivation Market Share by Application (2019-2024)
Table 25. Global Viral Inactivation Market Size Growth Rate by Application (2019-2024)
Table 26. Global Viral Inactivation Market Size by Region (2019-2024) & (M USD)
Table 27. Global Viral Inactivation Market Size Market Share by Region (2019-2024)
Table 28. North America Viral Inactivation Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Viral Inactivation Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Viral Inactivation Market Size by Region (2019-2024) & (M USD)
Table 31. South America Viral Inactivation Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Viral Inactivation Market Size by Region (2019-2024) & (M USD)
Table 33. Danaher Viral Inactivation Basic Information
Table 34. Danaher Viral Inactivation Product Overview
Table 35. Danaher Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Danaher Viral Inactivation SWOT Analysis
Table 37. Danaher Business Overview
Table 38. Danaher Recent Developments
Table 39. Merck Viral Inactivation Basic Information
Table 40. Merck Viral Inactivation Product Overview
Table 41. Merck Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Danaher Viral Inactivation SWOT Analysis
Table 43. Merck Business Overview
Table 44. Merck Recent Developments
Table 45. Parker Hannifin Viral Inactivation Basic Information
Table 46. Parker Hannifin Viral Inactivation Product Overview
Table 47. Parker Hannifin Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Danaher Viral Inactivation SWOT Analysis
Table 49. Parker Hannifin Business Overview
Table 50. Parker Hannifin Recent Developments
Table 51. Sartorius Viral Inactivation Basic Information
Table 52. Sartorius Viral Inactivation Product Overview
Table 53. Sartorius Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Sartorius Business Overview
Table 55. Sartorius Recent Developments
Table 56. SGS Viral Inactivation Basic Information
Table 57. SGS Viral Inactivation Product Overview
Table 58. SGS Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 59. SGS Business Overview
Table 60. SGS Recent Developments
Table 61. Charles River Laboratories International Viral Inactivation Basic Information
Table 62. Charles River Laboratories International Viral Inactivation Product Overview
Table 63. Charles River Laboratories International Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Charles River Laboratories International Business Overview
Table 65. Charles River Laboratories International Recent Developments
Table 66. Clean Cells Viral Inactivation Basic Information
Table 67. Clean Cells Viral Inactivation Product Overview
Table 68. Clean Cells Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Clean Cells Business Overview
Table 70. Clean Cells Recent Developments
Table 71. Rad Source Technologies Viral Inactivation Basic Information
Table 72. Rad Source Technologies Viral Inactivation Product Overview
Table 73. Rad Source Technologies Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Rad Source Technologies Business Overview
Table 75. Rad Source Technologies Recent Developments
Table 76. Texcell Viral Inactivation Basic Information
Table 77. Texcell Viral Inactivation Product Overview
Table 78. Texcell Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 79. Texcell Business Overview
Table 80. Texcell Recent Developments
Table 81. Viral Inactivated Plasma Systems Viral Inactivation Basic Information
Table 82. Viral Inactivated Plasma Systems Viral Inactivation Product Overview
Table 83. Viral Inactivated Plasma Systems Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Viral Inactivated Plasma Systems Business Overview
Table 85. Viral Inactivated Plasma Systems Recent Developments
Table 86. Wuxi Pharmatech (Cayman) Viral Inactivation Basic Information
Table 87. Wuxi Pharmatech (Cayman) Viral Inactivation Product Overview
Table 88. Wuxi Pharmatech (Cayman) Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 89. Wuxi Pharmatech (Cayman) Business Overview
Table 90. Wuxi Pharmatech (Cayman) Recent Developments
Table 91. Global Viral Inactivation Market Size Forecast by Region (2025-2030) & (M USD)
Table 92. North America Viral Inactivation Market Size Forecast by Country (2025-2030) & (M USD)
Table 93. Europe Viral Inactivation Market Size Forecast by Country (2025-2030) & (M USD)
Table 94. Asia Pacific Viral Inactivation Market Size Forecast by Region (2025-2030) & (M USD)
Table 95. South America Viral Inactivation Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Viral Inactivation Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Global Viral Inactivation Market Size Forecast by Type (2025-2030) & (M USD)
Table 98. Global Viral Inactivation Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Viral Inactivation Market Size Comparison by Region (M USD)
Table 5. Global Viral Inactivation Revenue (M USD) by Company (2019-2024)
Table 6. Global Viral Inactivation Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Inactivation as of 2022)
Table 8. Company Viral Inactivation Market Size Sites and Area Served
Table 9. Company Viral Inactivation Product Type
Table 10. Global Viral Inactivation Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Viral Inactivation
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Viral Inactivation Market Challenges
Table 18. Global Viral Inactivation Market Size by Type (M USD)
Table 19. Global Viral Inactivation Market Size (M USD) by Type (2019-2024)
Table 20. Global Viral Inactivation Market Size Share by Type (2019-2024)
Table 21. Global Viral Inactivation Market Size Growth Rate by Type (2019-2024)
Table 22. Global Viral Inactivation Market Size by Application
Table 23. Global Viral Inactivation Market Size by Application (2019-2024) & (M USD)
Table 24. Global Viral Inactivation Market Share by Application (2019-2024)
Table 25. Global Viral Inactivation Market Size Growth Rate by Application (2019-2024)
Table 26. Global Viral Inactivation Market Size by Region (2019-2024) & (M USD)
Table 27. Global Viral Inactivation Market Size Market Share by Region (2019-2024)
Table 28. North America Viral Inactivation Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Viral Inactivation Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Viral Inactivation Market Size by Region (2019-2024) & (M USD)
Table 31. South America Viral Inactivation Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Viral Inactivation Market Size by Region (2019-2024) & (M USD)
Table 33. Danaher Viral Inactivation Basic Information
Table 34. Danaher Viral Inactivation Product Overview
Table 35. Danaher Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Danaher Viral Inactivation SWOT Analysis
Table 37. Danaher Business Overview
Table 38. Danaher Recent Developments
Table 39. Merck Viral Inactivation Basic Information
Table 40. Merck Viral Inactivation Product Overview
Table 41. Merck Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Danaher Viral Inactivation SWOT Analysis
Table 43. Merck Business Overview
Table 44. Merck Recent Developments
Table 45. Parker Hannifin Viral Inactivation Basic Information
Table 46. Parker Hannifin Viral Inactivation Product Overview
Table 47. Parker Hannifin Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Danaher Viral Inactivation SWOT Analysis
Table 49. Parker Hannifin Business Overview
Table 50. Parker Hannifin Recent Developments
Table 51. Sartorius Viral Inactivation Basic Information
Table 52. Sartorius Viral Inactivation Product Overview
Table 53. Sartorius Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Sartorius Business Overview
Table 55. Sartorius Recent Developments
Table 56. SGS Viral Inactivation Basic Information
Table 57. SGS Viral Inactivation Product Overview
Table 58. SGS Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 59. SGS Business Overview
Table 60. SGS Recent Developments
Table 61. Charles River Laboratories International Viral Inactivation Basic Information
Table 62. Charles River Laboratories International Viral Inactivation Product Overview
Table 63. Charles River Laboratories International Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Charles River Laboratories International Business Overview
Table 65. Charles River Laboratories International Recent Developments
Table 66. Clean Cells Viral Inactivation Basic Information
Table 67. Clean Cells Viral Inactivation Product Overview
Table 68. Clean Cells Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Clean Cells Business Overview
Table 70. Clean Cells Recent Developments
Table 71. Rad Source Technologies Viral Inactivation Basic Information
Table 72. Rad Source Technologies Viral Inactivation Product Overview
Table 73. Rad Source Technologies Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Rad Source Technologies Business Overview
Table 75. Rad Source Technologies Recent Developments
Table 76. Texcell Viral Inactivation Basic Information
Table 77. Texcell Viral Inactivation Product Overview
Table 78. Texcell Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 79. Texcell Business Overview
Table 80. Texcell Recent Developments
Table 81. Viral Inactivated Plasma Systems Viral Inactivation Basic Information
Table 82. Viral Inactivated Plasma Systems Viral Inactivation Product Overview
Table 83. Viral Inactivated Plasma Systems Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Viral Inactivated Plasma Systems Business Overview
Table 85. Viral Inactivated Plasma Systems Recent Developments
Table 86. Wuxi Pharmatech (Cayman) Viral Inactivation Basic Information
Table 87. Wuxi Pharmatech (Cayman) Viral Inactivation Product Overview
Table 88. Wuxi Pharmatech (Cayman) Viral Inactivation Revenue (M USD) and Gross Margin (2019-2024)
Table 89. Wuxi Pharmatech (Cayman) Business Overview
Table 90. Wuxi Pharmatech (Cayman) Recent Developments
Table 91. Global Viral Inactivation Market Size Forecast by Region (2025-2030) & (M USD)
Table 92. North America Viral Inactivation Market Size Forecast by Country (2025-2030) & (M USD)
Table 93. Europe Viral Inactivation Market Size Forecast by Country (2025-2030) & (M USD)
Table 94. Asia Pacific Viral Inactivation Market Size Forecast by Region (2025-2030) & (M USD)
Table 95. South America Viral Inactivation Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Viral Inactivation Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Global Viral Inactivation Market Size Forecast by Type (2025-2030) & (M USD)
Table 98. Global Viral Inactivation Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Industrial Chain of Viral Inactivation
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Viral Inactivation Market Size (M USD), 2019-2030
Figure 5. Global Viral Inactivation Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Viral Inactivation Market Size by Country (M USD)
Figure 10. Global Viral Inactivation Revenue Share by Company in 2023
Figure 11. Viral Inactivation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Viral Inactivation Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Viral Inactivation Market Share by Type
Figure 15. Market Size Share of Viral Inactivation by Type (2019-2024)
Figure 16. Market Size Market Share of Viral Inactivation by Type in 2022
Figure 17. Global Viral Inactivation Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Viral Inactivation Market Share by Application
Figure 20. Global Viral Inactivation Market Share by Application (2019-2024)
Figure 21. Global Viral Inactivation Market Share by Application in 2022
Figure 22. Global Viral Inactivation Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Viral Inactivation Market Size Market Share by Region (2019-2024)
Figure 24. North America Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Viral Inactivation Market Size Market Share by Country in 2023
Figure 26. U.S. Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Viral Inactivation Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Viral Inactivation Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Viral Inactivation Market Size Market Share by Country in 2023
Figure 31. Germany Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Viral Inactivation Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Viral Inactivation Market Size Market Share by Region in 2023
Figure 38. China Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Viral Inactivation Market Size and Growth Rate (M USD)
Figure 44. South America Viral Inactivation Market Size Market Share by Country in 2023
Figure 45. Brazil Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Viral Inactivation Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Viral Inactivation Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Viral Inactivation Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Viral Inactivation Market Share Forecast by Type (2025-2030)
Figure 57. Global Viral Inactivation Market Share Forecast by Application (2025-2030)
Figure 1. Industrial Chain of Viral Inactivation
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Viral Inactivation Market Size (M USD), 2019-2030
Figure 5. Global Viral Inactivation Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Viral Inactivation Market Size by Country (M USD)
Figure 10. Global Viral Inactivation Revenue Share by Company in 2023
Figure 11. Viral Inactivation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Viral Inactivation Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Viral Inactivation Market Share by Type
Figure 15. Market Size Share of Viral Inactivation by Type (2019-2024)
Figure 16. Market Size Market Share of Viral Inactivation by Type in 2022
Figure 17. Global Viral Inactivation Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Viral Inactivation Market Share by Application
Figure 20. Global Viral Inactivation Market Share by Application (2019-2024)
Figure 21. Global Viral Inactivation Market Share by Application in 2022
Figure 22. Global Viral Inactivation Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Viral Inactivation Market Size Market Share by Region (2019-2024)
Figure 24. North America Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Viral Inactivation Market Size Market Share by Country in 2023
Figure 26. U.S. Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Viral Inactivation Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Viral Inactivation Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Viral Inactivation Market Size Market Share by Country in 2023
Figure 31. Germany Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Viral Inactivation Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Viral Inactivation Market Size Market Share by Region in 2023
Figure 38. China Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Viral Inactivation Market Size and Growth Rate (M USD)
Figure 44. South America Viral Inactivation Market Size Market Share by Country in 2023
Figure 45. Brazil Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Viral Inactivation Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Viral Inactivation Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Viral Inactivation Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Viral Inactivation Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Viral Inactivation Market Share Forecast by Type (2025-2030)
Figure 57. Global Viral Inactivation Market Share Forecast by Application (2025-2030)
